MacroGenics, Inc.

MacroGenics is a biopharmaceutical company specializing in the development and commercialization of innovative monoclonal antibody-based therapeutics, primarily focusing on cancer treatment. Their pipeline of product candidates is generated from proprietary next-generation antibody-based technology platforms, showcasing their expertise in protein engineering. MacroGenics' strategic collaborations with global pharmaceutical and biotechnology companies further strengthen their reach and impact in the industry.

MacroGenics is committed to their living values which prioritize patients, ethical practices, innovation, collaboration, and proactive action. Their corporate responsibility initiatives demonstrate their dedication to ESG (Environmental, Social, and Governance) principles, highlighting their commitment to building a safe and sustainable business while making a positive impact on society.

MacroGenics offers several benefits to its employees, including 10 paid holidays per year, plus one floating holiday, as well as a winter break closure from Christmas to New Year's Day. However, no information about job flexibility or remote work options is available.

MacroGenics offers a comprehensive benefits package to its employees, including paid vacation, sick leave, and ten holidays per year. They provide health, dental, and vision insurance plans as well as a 401(k) plan with a company match, pre-tax and Roth savings options, and no vesting period. Employees also have access to a stock option plan, an employee stock option purchase plan, an onsite fitness center at headquarters, flexible spending accounts, a wellness program, annual fitness reimbursements, tuition reimbursement, an employee assistance program, and employer-paid group term life, accidental death and dismemberment insurance, and short- and long-term disability.

MacroGenics, a biopharmaceutical company, is dedicated to developing and commercializing innovative monoclonal antibody-based therapeutics that transform the lives of patients with cancer. Their mission focuses on creating life-changing medicines by leveraging their expertise in protein engineering and other technical capabilities, fostering teamwork among employees, and committing to excellence in all endeavors. They strive to build a safe, environmentally responsible, and ethical business to positively impact society and deliver long-term value to stakeholders, including employees, partners, patients, and stockholders.

MacroGenics fosters a culture of innovation, open communication, and collaboration, where employees are considered the company's most valuable asset. The company prioritizes professional development and encourages teamwork, ensuring everyone feels valued and contributes to the overall success of the organization. MacroGenics prioritizes a culture that is patient-centric, ethical, and values diversity and inclusion.

MacroGenics promotes a culture of inclusion and celebrates diversity by ensuring that employment decisions are made without regard to race, color, national origin, sex, gender identity, sexual orientation, religion, age, disability, protected veteran status, or any other characteristic protected by law. They actively seek to foster an environment where everyone feels a sense of belonging and are committed to working with and providing reasonable accommodation to individuals with disabilities.